Discordance between proptosis response and other clinical improvements at week 12 during teprotumumab N01 therapy for thyroid eye disease: a multicenter prospective registry study
- DOI
- 10.1186/s12886-026-05476-3
- Published
- 2026-10-27
- Container
- BMC Ophthalmology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12886-026-05476-3,
title = {Discordance between proptosis response and other clinical improvements at week 12 during teprotumumab N01 therapy for thyroid eye disease: a multicenter prospective registry study},
author = {Wenjing Gao and Bojing Yan and Junyu Hu and Dongmei Li and Lihua Luo},
year = {2026},
journal = {BMC Ophthalmology},
doi = {10.1186/s12886-026-05476-3},
url = {https://doi.org/10.1186/s12886-026-05476-3}
}RIS
TY - JOUR TI - Discordance between proptosis response and other clinical improvements at week 12 during teprotumumab N01 therapy for thyroid eye disease: a multicenter prospective registry study AU - Wenjing Gao AU - Bojing Yan AU - Junyu Hu AU - Dongmei Li AU - Lihua Luo PY - 2026 JO - BMC Ophthalmology DO - 10.1186/s12886-026-05476-3 UR - https://doi.org/10.1186/s12886-026-05476-3 ER -
APA
Gao, W., Yan, B., Hu, J., Li, D., & Luo, L. (2026). Discordance between proptosis response and other clinical improvements at week 12 during teprotumumab N01 therapy for thyroid eye disease: a multicenter prospective registry study. BMC Ophthalmology. https://doi.org/10.1186/s12886-026-05476-3
Source records
- crossref · retrieved 2026-11-10T18:53:05.549Z